Free Trial

Nutrien (NYSE:NTR) Stock Rating Lowered by Wall Street Zen

Nutrien logo with Basic Materials background

Key Points

  • Wall Street Zen has downgraded Nutrien from a "strong-buy" rating to a "buy" rating, reflecting a shift in analyst sentiment.
  • Oppenheimer and TD Securities both raised their price targets for Nutrien, indicating continued positive outlooks with targets set at $65.00 and $72.00 respectively.
  • Nutrien's stock is currently trading at $56.39, with a market cap of $27.41 billion, and has recently posted better-than-expected quarterly earnings.
  • Five stocks we like better than Nutrien.

Wall Street Zen cut shares of Nutrien (NYSE:NTR - Free Report) from a strong-buy rating to a buy rating in a research note released on Friday.

Several other brokerages also recently commented on NTR. National Bank Financial initiated coverage on Nutrien in a research note on Friday, September 5th. They issued a "sector perform" rating for the company. Scotiabank cut their target price on Nutrien from $62.00 to $60.00 and set a "sector perform" rating for the company in a research note on Monday, August 11th. Morgan Stanley raised their target price on Nutrien from $60.00 to $65.00 and gave the stock an "equal weight" rating in a research note on Thursday, June 26th. TD Securities raised their target price on Nutrien from $70.00 to $72.00 and gave the stock a "buy" rating in a research note on Monday, August 11th. Finally, Zacks Research upgraded Nutrien from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $62.39.

Check Out Our Latest Stock Report on Nutrien

Nutrien Stock Performance

Shares of NTR stock traded down $0.28 on Friday, hitting $57.13. 2,922,391 shares of the stock were exchanged, compared to its average volume of 2,080,312. The company has a current ratio of 1.33, a quick ratio of 0.85 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $27.72 billion, a PE ratio of 20.48, a P/E/G ratio of 0.96 and a beta of 0.77. Nutrien has a one year low of $43.69 and a one year high of $65.08. The firm's 50 day moving average is $58.48 and its two-hundred day moving average is $56.25.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share for the quarter, topping the consensus estimate of $2.41 by $0.24. The company had revenue of $10.30 billion during the quarter, compared to the consensus estimate of $10.40 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%.The firm's quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.34 EPS. Sell-side analysts expect that Nutrien will post 3.72 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Monday, September 29th will be given a dividend of $0.545 per share. The ex-dividend date is Monday, September 29th. This represents a $2.18 annualized dividend and a dividend yield of 3.8%. Nutrien's payout ratio is currently 78.14%.

Institutional Investors Weigh In On Nutrien

Hedge funds have recently added to or reduced their stakes in the stock. Harbour Investments Inc. boosted its holdings in Nutrien by 94.8% in the first quarter. Harbour Investments Inc. now owns 715 shares of the company's stock worth $35,000 after acquiring an additional 348 shares in the last quarter. Huntington National Bank raised its stake in shares of Nutrien by 72.6% in the second quarter. Huntington National Bank now owns 656 shares of the company's stock worth $38,000 after purchasing an additional 276 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Nutrien by 42.4% in the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company's stock worth $43,000 after purchasing an additional 219 shares during the last quarter. Trust Co. of Toledo NA OH purchased a new position in shares of Nutrien in the second quarter worth $49,000. Finally, Allworth Financial LP raised its stake in shares of Nutrien by 117.1% in the first quarter. Allworth Financial LP now owns 938 shares of the company's stock worth $50,000 after purchasing an additional 506 shares during the last quarter. 63.10% of the stock is owned by institutional investors.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.